Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sherr, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherr, C. J.
[Cancer Research 60, 3689-3695, July 15, 2000]
© 2000 American Association for Cancer Research

Special Lecture

The Pezcoller Lecture: Cancer Cell Cycles Revisited

Charles J. Sherr1

Howard Hughes Medical Institute and Department of Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

ABSTRACT

Genetic lesions that disable key regulators of G1 phase progression in mammalian cells are present in most human cancers. Mitogen-dependent, cyclin D-dependent kinases (cdk4 and cdk6) phosphorylate the retinoblastoma (Rb) tumor suppressor protein, helping to cancel its growth-inhibitory effects and enabling E2F transcription factors to activate genes required for entry into the DNA synthetic phase (S) of the cell division cycle. Among the E2F-responsive genes are cyclins E and A, which combine with and activate cdk2 to facilitate S phase entry and progression. Accumulation of cyclin D-dependent kinases during G1 phase sequesters cdk2 inhibitors of the Cip/Kip family, complementing the effects of the E2F transcriptional program by facilitating cyclin E-cdk2 activation at the G1-S transition. Disruption of "the Rb pathway" results from direct mutational inactivation of Rb function, by overexpression of cyclin D-dependent kinases, or through loss of p16INK4a, an inhibitor of the cyclin D-dependent kinases. Reduction in levels of p27Kip1 and increased expression of cyclin E also occur and carry a poor prognostic significance in many common forms of cancer. The ARF tumor suppressor, encoded by an alternative reading frame of the INK4a-ARF locus, senses "mitogenic current" flowing through the Rb pathway and is induced by abnormal growth promoting signals. By antagonizing Mdm2, a negative regulator of the p53 tumor suppressor, ARF triggers a p53-dependent transcriptional response that diverts incipient cancer cells to undergo growth arrest or apoptosis. Although ARF is not directly activated by signals that damage DNA, its loss not only dampens the p53 response to abnormal mitogenic signals but also renders tumor cells resistant to treatment by cytotoxic drugs and irradiation. Lesions in the p16 — cyclin D-CDK4 — Rb and ARF — Mdm2 — p53 pathways occur so frequently in cancer, regardless of patient age or tumor type, that they appear to be part of the life history of most, if not all, cancer cells.




This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
D. E. Freedberg, S. H. Rigas, J. Russak, W. Gai, M. Kaplow, I. Osman, F. Turner, J. A. Randerson-Moor, A. Houghton, K. Busam, et al.
Frequent p16-Independent Inactivation of p14ARF in Human Melanoma
J Natl Cancer Inst, June 4, 2008; 100(11): 784 - 795.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Derenzini, G. Donati, G. Mazzini, L. Montanaro, M. Vici, C. Ceccarelli, D. Santini, M. Taffurelli, and D. Trere
Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure
Clin. Cancer Res., April 1, 2008; 14(7): 2199 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S.S. Han, J.H. No, Y.T. Jeon, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee
Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2
Hum. Reprod., March 1, 2008; 23(3): 525 - 529.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Weber, M. K. Corbett, L. M. L. Chow, M. B. Valentine, S. J. Baker, and J. Zuo
Rapid cell-cycle reentry and cell death after acute inactivation of the retinoblastoma gene product in postnatal cochlear hair cells
PNAS, January 15, 2008; 105(2): 781 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. M. Bentley, G. Normand, J. Hoyt, and R. W. King
Distinct Sequence Elements of Cyclin B1 Promote Localization to Chromatin, Centrosomes, and Kinetochores during Mitosis
Mol. Biol. Cell, December 1, 2007; 18(12): 4847 - 4858.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. V. Das, J. James, S. Bhattacharya, A. N. Imbalzano, M. L. Antony, G. Hegde, X. Zhao, K. Mallya, F. Ahmad, E. Knudsen, et al.
SWI/SNF Chromatin Remodeling ATPase Brm Regulates the Differentiation of Early Retinal Stem Cells/Progenitors by Influencing Brn3b Expression and Notch Signaling
J. Biol. Chem., November 30, 2007; 282(48): 35187 - 35201.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
S. B. Glickstein, H. Moore, B. Slowinska, J. Racchumi, M. Suh, N. Chuhma, and M. E. Ross
Selective cortical interneuron and GABA deficits in cyclin D2-null mice
Development, November 15, 2007; 134(22): 4083 - 4093.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Koslowski, U. Sahin, R. Mitnacht-Kraus, G. Seitz, C. Huber, and O. Tureci
A Placenta-Specific Gene Ectopically Activated in Many Human Cancers Is Essentially Involved in Malignant Cell Processes
Cancer Res., October 1, 2007; 67(19): 9528 - 9534.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
A. Lee, W. C. Park, H. W. Yim, M. A. Lee, G. Park, and K. Y. Lee
Expression of c-erbB2, cyclin D1 and Estrogen Receptor and their Clinical Implications in the Invasive Ductal Carcinoma of the Breast
Jpn. J. Clin. Oncol., September 1, 2007; 37(9): 708 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. M. Alonso, M. Cascallo, C. Gomez-Manzano, H. Jiang, B. N. Bekele, A. Perez-Gimenez, F. F. Lang, Y. Piao, R. Alemany, and J. Fueyo
ICOVIR-5 Shows E2F1 Addiction and Potent Antiglioma Effect In vivo
Cancer Res., September 1, 2007; 67(17): 8255 - 8263.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
G. M. Lehmann and M. J. McCabe Jr
Arsenite Slows S Phase Progression via Inhibition of cdc25A Dual Specificity Phosphatase Gene Transcription
Toxicol. Sci., September 1, 2007; 99(1): 70 - 78.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K.-W. Lee, H. J. Kim, Y. S. Lee, H.-J. Park, J.-W. Choi, J. Ha, and K.-T. Lee
Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte
Carcinogenesis, September 1, 2007; 28(9): 1928 - 1936.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
S. P. Fosmire, R. Thomas, C. M. Jubala, J. W. Wojcieszyn, V. E. O. Valli, D. M. Getzy, T. L. Smith, L. A. Gardner, M. G. Ritt, J. S. Bell, et al.
Inactivation of the p16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin's T-Cell Lymphoma
Vet. Pathol., July 1, 2007; 44(4): 467 - 478.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Ruas, F. Gregory, R. Jones, R. Poolman, M. Starborg, J. Rowe, S. Brookes, and G. Peters
CDK4 and CDK6 Delay Senescence by Kinase-Dependent and p16INK4a-Independent Mechanisms
Mol. Cell. Biol., June 15, 2007; 27(12): 4273 - 4282.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Matsumoto, S. Yu, Y. Jia, M. R. Ahmed, N. Viswakarma, J. Sarkar, P. V. Kashireddy, M. Sambasiva Rao, W. Karpus, F. J. Gonzalez, et al.
Critical Role for Transcription Coactivator Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein/TRAP220 in Liver Regeneration and PPAR{alpha} Ligand-induced Liver Tumor Development
J. Biol. Chem., June 8, 2007; 282(23): 17053 - 17060.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
K. R. Barnett, D. Tomic, R. K. Gupta, K. P. Miller, S. Meachum, T. Paulose, and J. A. Flaws
The Aryl Hydrocarbon Receptor Affects Mouse Ovarian Follicle Growth via Mechanisms Involving Estradiol Regulation and Responsiveness
Biol Reprod, June 1, 2007; 76(6): 1062 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Shu, S. Lv, Y. Qin, X. Ma, X. Wang, X. Peng, Y. Luo, B.-e Xu, X. Sun, and J. Wu
Functional characterization of human PFTK1 as a cyclin-dependent kinase
PNAS, May 29, 2007; 104(22): 9248 - 9253.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
I. Perez de Castro, G. de Carcer, and M. Malumbres
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
Carcinogenesis, May 1, 2007; 28(5): 899 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Ray, Y. Terao, P. G. Fuhrken, Z.-Q. Ma, F. J. DeMayo, K. Christov, N. A. Heerema, R. Franks, S. Y. Tsai, E. T. Papoutsakis, et al.
Deregulated CDC25A Expression Promotes Mammary Tumorigenesis with Genomic Instability
Cancer Res., February 1, 2007; 67(3): 984 - 991.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Jiang, P. J. Mikochik, J. H. Ra, H. Lei, K. T. Flaherty, J. D. Winkler, and F. R. Spitz
HIV Protease Inhibitor Nelfinavir Inhibits Growth of Human Melanoma Cells by Induction of Cell Cycle Arrest
Cancer Res., February 1, 2007; 67(3): 1221 - 1227.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. W. Upton and S. H. Speck
Evidence for CDK-Dependent and CDK-Independent Functions of the Murine Gammaherpesvirus 68 v-Cyclin
J. Virol., December 15, 2006; 80(24): 11946 - 11959.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Zhou, H. Kitaura, S. L. Teitelbaum, G. Krystal, F. P. Ross, and S. Takeshita
SHIP1 Negatively Regulates Proliferation of Osteoclast Precursors via Akt-Dependent Alterations in D-Type Cyclins and p27
J. Immunol., December 15, 2006; 177(12): 8777 - 8784.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Yang, S. Wu, X. Su, and W. S. May
JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity
Blood, December 15, 2006; 108(13): 4136 - 4145.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Mukhopadhyay, E. A. Sausville, J. H. Doroshow, and K. K. Roy
Molecular Mechanism of Adaphostin-mediated G1 Arrest in Prostate Cancer (PC-3) Cells: SIGNALING EVENTS MEDIATED BY HEPATOCYTE GROWTH FACTOR RECEPTOR, c-Met, AND p38 MAPK PATHWAYS
J. Biol. Chem., December 8, 2006; 281(49): 37330 - 37344.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. GRDISA, A.-M. MIKECIN, and M. POZNIC
Does Transduced p27 Induce Apoptosis in Human Tumor Cell Lines?
Ann. N.Y. Acad. Sci., December 1, 2006; 1090(1): 120 - 129.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Y. Locker, S. Hamilton, J. Harris, J. M. Jessup, N. Kemeny, J. S. Macdonald, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
J. Clin. Oncol., November 20, 2006; 24(33): 5313 - 5327.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R. P Singh and R. Agarwal
Mechanisms of action of novel agents for prostate cancer chemoprevention.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 751 - 778.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J.-H. Chung, M. C. Ostrowski, T. Romigh, T. Minaguchi, K. A. Waite, and C. Eng
The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation
Hum. Mol. Genet., September 1, 2006; 15(17): 2553 - 2559.
[Abstract] [Full Text] [PDF]

Home page
 GENES CELLSHome page
B. Wang, J. Tsukada, T. Higashi, T. Mizobe, A. Matsuura, F. Mouri, N. Sawamukai, C. Ra, and Y. Tanaka
Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
Genes Cells, September 1, 2006; 11(9): 983 - 992.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
P. Garcia-Morales, E. Hernando, E. Carrasco-Garcia, M. P. Menendez-Gutierrez, M. Saceda, and I. Martinez-Lacaci
Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells.
Mol. Cancer Ther., September 1, 2006; 5(9): 2172 - 2181.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
R. Huang, A. Wallqvist, and D. G. Covell
Targeting changes in cancer: assessing pathway stability by comparing pathway gene expression coherence levels in tumor and normal tissues.
Mol. Cancer Ther., September 1, 2006; 5(9): 2417 - 2427.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. F. Dai, Y. Zhang, Y. Kang, Q. Wang, H. Y. Gaisano, K.-H. Braunewell, C. B. Chan, and M. B. Wheeler
The Neuronal Ca2+ Sensor Protein Visinin-like Protein-1 Is Expressed in Pancreatic Islets and Regulates Insulin Secretion
J. Biol. Chem., August 4, 2006; 281(31): 21942 - 21953.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. R. Croft and M. F. Olson
The Rho GTPase Effector ROCK Regulates Cyclin A, Cyclin D1, and p27Kip1 Levels by Distinct Mechanisms
Mol. Cell. Biol., June 15, 2006; 26(12): 4612 - 4627.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. W. Schnepp, Y.-X. Chen, H. Wang, T. Cash, A. Silva, J. A. Diehl, E. Brown, and X. Hua
Mutation of Tumor Suppressor Gene Men1 Acutely Enhances Proliferation of Pancreatic Islet Cells
Cancer Res., June 1, 2006; 66(11): 5707 - 5715.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. Shakhova, C. Leung, E. van Montfort, A. Berns, and S. Marino
Lack of Rb and p53 Delays Cerebellar Development and Predisposes to Large Cell Anaplastic Medulloblastoma through Amplification of N-Myc and Ptch2.
Cancer Res., May 15, 2006; 66(10): 5190 - 5200.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Spaziani, A. Alisi, D. Sanna, and C. Balsano
Role of p38 MAPK and RNA-dependent Protein Kinase (PKR) in Hepatitis C Virus Core-dependent Nuclear Delocalization of Cyclin B1
J. Biol. Chem., April 21, 2006; 281(16): 10983 - 10989.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. J. Oh, A. Razfar, I. Delgado, R. A. Reed, A. Malkina, B. Boctor, and D. J. Slamon
3p21.3 Tumor Suppressor Gene H37/Luca15/RBM5 Inhibits Growth of Human Lung Cancer Cells through Cell Cycle Arrest and Apoptosis.
Cancer Res., April 1, 2006; 66(7): 3419 - 3427.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
M. J. Worsham, K. M. Chen, N. Tiwari, G. Pals, J. P. Schouten, S. Sethi, and M. S. Benninger
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg, April 1, 2006; 132(4): 409 - 415.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Ouyang, J. Li, Q. Ma, and C. Huang
Essential roles of PI-3K/Akt/IKK{beta}/NF{kappa}B pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells
Carcinogenesis, April 1, 2006; 27(4): 864 - 873.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Tzankov, A. Gschwendtner, F. Augustin, M. Fiegl, E. C. Obermann, S. Dirnhofer, and P. Went
Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
Clin. Cancer Res., April 1, 2006; 12(7): 2125 - 2132.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
P. Potemski, E. Pluciennik, A. K. Bednarek, R. Kusinska, D. Jesionek-Kupnicka, G. Pasz-Walczak, C. Watala, and R. Kordek
Cyclin E Expression in Operable Breast Cancer Quantified Using Real-Time RT-PCR: A Comparative Study with Immunostaining
Jpn. J. Clin. Oncol., March 1, 2006; 36(3): 142 - 149.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S.J. Weroha, S. A. Li, O. Tawfik, and J. J. Li
Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats
Carcinogenesis, March 1, 2006; 27(3): 491 - 498.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. W. Woodmansee, J. M. Kerr, E. A. Tucker, J. R. Mitchell, D. J. Haakinson, D. F. Gordon, E. C. Ridgway, and W. M. Wood
The Proliferative Status of Thyrotropes Is Dependent on Modulation of Specific Cell Cycle Regulators by Thyroid Hormone
Endocrinology, January 1, 2006; 147(1): 272 - 282.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Cannon, E. Cesarman, and C. Boshoff
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2
Blood, January 1, 2006; 107(1): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. K. Schwartz and M. A. Shah
Targeting the Cell Cycle: A New Approach to Cancer Therapy
J. Clin. Oncol., December 20, 2005; 23(36): 9408 - 9421.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. K.D.L. Reddy, R. V. Mettus, S. G. Rane, X. Grana, J. Litvin, and E. P. Reddy
Cyclin-Dependent Kinase 4 Expression Is Essential for Neu-Induced Breast Tumorigenesis
Cancer Res., November 15, 2005; 65(22): 10174 - 10178.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
R. Nimmo, A. Antebi, and A. Woollard
mab-2 encodes RNT-1, a C. elegans Runx homologue essential for controlling cell proliferation in a stem cell-like developmental lineage
Development, November 15, 2005; 132(22): 5043 - 5054.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C. C. LEOW, P. POLAKIS, and W.-Q. GAO
A Role for Hath1, a bHLH Transcription Factor, in Colon Adenocarcinoma
Ann. N.Y. Acad. Sci., November 1, 2005; 1059(1): 174 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Yang, L. Bancroft, J. Liang, M. Zhuang, and L. H. Augenlicht
p27kip1 in Intestinal Tumorigenesis and Chemoprevention in the Mouse
Cancer Res., October 15, 2005; 65(20): 9363 - 9368.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Belanger, P. Beaulieu, C. Moreau, D. Labuda, T. J. Hudson, and D. Sinnett
Functional promoter SNPs in cell cycle checkpoint genes
Hum. Mol. Genet., September 15, 2005; 14(18): 2641 - 2648.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. D. Putnam, V. Pennaneach, and R. D. Kolodner
Saccharomyces cerevisiae as a Model System To Define the Chromosomal Instability Phenotype
Mol. Cell. Biol., August 15, 2005; 25(16): 7226 - 7238.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. M. Moser, J. W. Upton, R. D. Allen III, C. B. Wilson, and S. H. Speck
Role of B-Cell Proliferation in the Establishment of Gammaherpesvirus Latency
J. Virol., August 1, 2005; 79(15): 9480 - 9491.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Yuste, J. C. Montero, A. Esparis-Ogando, and A. Pandiella
Activation of ErbB2 by Overexpression or by Transmembrane Neuregulin Results in Differential Signaling and Sensitivity to Herceptin
Cancer Res., August 1, 2005; 65(15): 6801 - 6810.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
K. Leibundgut, N. M.R. Schmitz, and A. Hirt
Catalytic Activities of G1 Cyclin-Dependent Kinases and Phosphorylation of Retinoblastoma Protein in Mobilized Peripheral Blood CD34+ Hematopoietic Progenitor Cells
Stem Cells, August 1, 2005; 23(7): 1002 - 1011.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. M. Fraser, P. M. Watson, M. M. Fraig, J. R. Kelley, P. S. Nelson, A. M. Boylan, D. J. Cole, and D. K. Watson
CaSm-Mediated Cellular Transformation Is Associated with Altered Gene Expression and Messenger RNA Stability
Cancer Res., July 15, 2005; 65(14): 6228 - 6236.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. I. Raynaud, S. R. Whittaker, P. M. Fischer, S. McClue, M. I. Walton, S. E. Barrie, M. D. Garrett, P. Rogers, S. J. Clarke, L. R. Kelland, et al.
In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202
Clin. Cancer Res., July 1, 2005; 11(13): 4875 - 4887.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. G. Rodriguez-Mora, M. M. LaHair, J. A. McCubrey, and R. A. Franklin
Calcium/Calmodulin-Dependent Kinase I and Calcium/Calmodulin-Dependent Kinase Kinase Participate in the Control of Cell Cycle Progression in MCF-7 Human Breast Cancer Cells
Cancer Res., June 15, 2005; 65(12): 5408 - 5416.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Bueso-Ramos, Y. Xu, T. J. McDonnell, S. Brisbay, S. Pierce, H. Kantarjian, G. Rosner, and G. Garcia-Manero
Protein Expression of a Triad of Frequently Methylated Genes, p73, p57Kip2, and p15, Has Prognostic Value in Adult Acute Lymphocytic Leukemia Independently of Its Methylation Status
J. Clin. Oncol., June 10, 2005; 23(17): 3932 - 3939.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Wessely
Interference by interferons: Janus faces in vascular proliferative diseases
Cardiovasc Res, June 1, 2005; 66(3): 433 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. A. Kushner, M. A. Ciemerych, E. Sicinska, L. M. Wartschow, M. Teta, S. Y. Long, P. Sicinski, and M. F. White
Cyclins D2 and D1 Are Essential for Postnatal Pancreatic {beta}-Cell Growth
Mol. Cell. Biol., May 1, 2005; 25(9): 3752 - 3762.
[Abstract] [Full Text] [PDF]